According to the Zhitong Finance App, Federal Pharmaceuticals (03933.HK) announced that the Group's net profit for the six months ending June 30, 2026 is expected to be approximately RMB 340 million (same in units), while net profit for the six months ended June 30, 2025 is approximately RMB 1,893 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.